Please login to the form below

Not currently logged in
Email:
Password:

WPP announces global strategic partnership with Twitter

Agreement will enable WPP to integrate Twitter data into its campaign targeting

WPP logo

WPP and Twitter have announced a partnership deal that will enable the advertising network to integrate Twitter data into its media and analytics platforms.

The partnership spans multiple WPP units, including GroupM, Kantar and digital agency Wunderman.

WPP said in a statement that it is committed to working with Twitter to extend the Group's lead in data-driven marketing. As part of the deal WPP companies from a variety of disciplines will increasingly leverage Twitter data across a number of important initiatives to deliver more effective campaigns, enhanced targeting and more real-time insight to clients.

Sir Martin Sorrell, WPP chief executive, said: "Twitter's relevance continues to grow – not only as a social platform, but also as a window into consumer attitudes and behaviour in real time.

"We are delighted to announce this very wide-ranging strategic partnership and to ensure that Twitter data is a key ingredient in many of our disciplines. We look forward to leveraging the platform in a variety of ways for our clients around the world."

Dick Costolo, CEO of Twitter, said: “We're excited to forge this global partnership with WPP. As Twitter has grown, marketers are leveraging the platform for brand insights, relevant real-time messaging and customer research. This partnership will benefit clients by pairing Twitter with WPP's world-class analytics, targeting and creative capabilities.”

The partnership will also see the launch of new data products and services.

The financial arrangements have not been disclosed.

14th June 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Conversis

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics